Veraxa Biotech Holding AG

NASDAQ:VRXA

Biotechnology

Healthcare
$1.03 -27.30%

-$1.60 today

Market cap
$145.65M
Beta
-0.40
52W Low $4.20High $27.36

Volume 0.10M

Average 0.02M

Returns on capital

Veraxa Biotech Holding AG management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management

No return metrics data available.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Christoph Antz

Co-Founder, Lead Director & CEO—64——

Christoph Erkel

Chief Scientific Officer—49——

Heinz Schwer

Chief Business Officer—58——

Carl von Halem

Principal Financial Officer & Principal Accounting Officer——0<0.01%

Raju Willener

Chief Financial Officer————

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Jul 10, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

5

$125,332.66

Sells

0

$0.00

Net Transaction Value

+$125,332.66

Net buying

Most Active

Gruninger Marc

2 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Oct 28, 26

Gruninger Marc

Direct

Buy$9.1K
Oct 27, 26

Gruninger Marc

Direct

Buy$849.7
Oct 20, 26

Ziegler Christoph Samuel

Direct

Buy$32.7K
Aug 27, 26

Baumann Oliver Rolf

Indirect

Buy$75K
Aug 27, 26

Antz Christoph Rudiger

Direct

Buy$7.7K

Summary

Insiders reported 5 buys worth $125,332.66 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $125,332.66. Gruninger Marc was the most active insider with 2 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

No growth data available

Competitors

Who does Veraxa Biotech Holding AG compete with?

Open similar companies to compare how their management teams allocate capital.

Competitors

Peer companies in the same sector

Health

No competitor data available.

Questions

Management questions

Common questions about VRXA's management, answered from reported figures.

Who manages VRXA?

Veraxa Biotech Holding AG (VRXA) lists 5 active executives. The top listed executive is Christoph Antz, Co-Founder, Lead Director & CEO.

Are VRXA insiders buying or selling?

Recent insider activity shows net buying of $125,332.66.